Julie Bellemans

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Escherichia Coli

Mesenchymal Stem Cells

Top Venues

Applied microbiology and biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)
Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)
Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)
Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)
Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)
Niels Vander Elst, Julie Bellemans, Rob Lavigne, Yves Briers, Evelyne Meyer
Endolysin NC5 improves early cloxacillin treatment in a mouse model of Streptococcus uberis mastitis. Applied microbiology and biotechnology 108 (1) (2024)